GEN Exclusives

More »

New Products

Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop. Conveniently categorized and searchable, the database covers the latest innovations from industry-leading suppliers.

AMS Biotechnology

  • Page 1 of 1 (4 items) 1 

siRNA Generation

AMS Biotechnology

The Dicer siRNA Generation Kit can mimic the natural RNA interference process by using recombinant human dicer enzyme, a double-stranded RNA-specific endonuclease, to cleave in vitro transcribed dsRNA templates into a pool of 22 bp siRNAs. Each ...

Ebola Antigens and Antibodies for ELISA

AMS Biotechnology

Diagnosing Ebola can be a challenge because the early symptoms are nonspecific to Ebola infection and are often seen in patients with more commonly occurring diseases, such as malaria and typhoid fever. Accurate diagnostics are essential in cont...

Neuro Transfection Reagent

AMS Biotechnology

Neurons are among the most difficult cell types to transfect. DNA-In™ Neuro is a new generation transfection reagent developed specifically for maximum nucleic acid delivery into neurons. The reagent offers researchers a cost-effective...

Validated Monoclonal Antibodies

AMS Biotechnology

The UltraMAB™ monoclonal antibodies were the result of screening candidate antibodies against more than 10,000 human proteins using a High Density Protein Microarray Platform. The validated monoclonal antibodies are available for cance...

  • Page 1 of 1 (4 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »